Satish Pillai

Satish Pillai is a Professor at the University of California, San Francisco (UCSF), with affiliations at the Gladstone Institute of Virology and Immunology (GIVI). His research focuses on understanding host antiviral mechanisms, particularly the role of interferon-alpha (IFN-α) in suppressing HIV-1 replication. Pillai investigates how intrinsic cellular inhibitors like APOBEC3 and BST-2/tetherin contribute to HIV latency and viral persistence, aiming to develop novel therapeutic strategies targeting these host factors.

His work integrates systems biology approaches, including single-cell sequencing and bioinformatics, to dissect viral evolution and immune responses in HIV-infected individuals. Collaborations with institutions like the San Francisco VA Medical Center and Gladstone Institute highlight his interdisciplinary research. Key areas include HIV reservoir dynamics, SARS-CoV-2 antiviral drug development, and the role of galectin-9 in viral pathogenesis.

Pillai’s lab receives funding from NIH (NIAID, NIMH, etc.) and amfAR. His studies have advanced understanding of HIV latency, interferon signaling, and host-virus interactions, with implications for cure strategies and antiviral therapies.